Clinical Trials Browser

OTHER × Essential Hypertension × Adrenergic beta-Antagonists × Clear all

NCT05972785 2024-08-21

Long-term Use of CCB and Breast Cancer Risk

Active not recruiting

68,500 enrolled

Essential Hypertension, Breast Neoplasms